- Conditions
- Critical Limb Ischemia, Peripheral Vascular Disease
- Interventions
- Mesendo
- Biological
- Lead sponsor
- TCA Cellular Therapy
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 1
- States / cities
- Covington, Louisiana
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 28
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Peripheral Arterial Disease, Critical Limb Ischemia
- Interventions
- BOLD-MRI
- Other
- Lead sponsor
- Zimmer Biomet
- Industry
- Eligibility
- 19 Years to 89 Years
- Enrollment
- 5 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016
- U.S. locations
- 1
- States / cities
- Springfield, Illinois
- Conditions
- Critical Limb Ischemia
- Interventions
- VM202 2 mg, VM202 4 mg, VM202 8 mg, VM202 16 mg
- Biological
- Lead sponsor
- Helixmith Co., Ltd.
- Industry
- Eligibility
- 20 Years to 90 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2023
- U.S. locations
- 1
- States / cities
- Minneapolis, Minnesota
- Conditions
- Chronic Critical Limb Ischemia, Peripheral Vascular Diseases
- Interventions
- Xpert(TM) Self-expanding Transhepatic Biliary Stent System feasibility in treating chronic critical limb ischemia
- Device
- Lead sponsor
- VIVA Physicians
- Other
- Eligibility
- 18 Years to 89 Years
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2011
- U.S. locations
- 1
- States / cities
- San Jose, California
- Conditions
- Critical Limb Ischemia
- Interventions
- treprostinil dienthanolmine sustained release, Placebo
- Drug
- Lead sponsor
- Ochsner Health System
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 1
- States / cities
- New Orleans, Louisiana
- Conditions
- Peripheral Vascular Disease
- Interventions
- Ecraprost in lipid emulsion
- Drug
- Lead sponsor
- Tanabe Pharma Corporation
- Industry
- Eligibility
- 40 Years and older
- Enrollment
- 280 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2001 – 2005
- U.S. locations
- 15
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Glendale, California + 12 more
- Conditions
- Diabetes Mellitus, Critical Limb Ischemia, Lower Limb Amputation Knee, Peripheral Arterial Disease
- Interventions
- Active Arm N-acetyl cysteine (NAC), Placebo Arm
- Drug
- Lead sponsor
- Washington University School of Medicine
- Other
- Eligibility
- 30 Years to 90 Years
- Enrollment
- 33 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2022
- U.S. locations
- 1
- States / cities
- St Louis, Missouri
- Conditions
- Critical Limb Ischemia, Ischemia, Leg Ulcer
- Interventions
- pVGI.1 (VEGF-2)
- Genetic
- Lead sponsor
- Losordo, Douglas, M.D.
- Individual
- Eligibility
- 21 Years and older
- Timeline
- Ends 2008
- U.S. locations
- 3
- States / cities
- Birmingham, Alabama • Boston, Massachusetts • Minneapolis, Minnesota
- Conditions
- Critical Limb Ischemia
- Interventions
- ArtAssist© Device
- Device
- Lead sponsor
- Temple University
- Other
- Eligibility
- 21 Years and older
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2019
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Critical Limb Ischemia, Peripheral Vascular Disease, Foot Ulcers, Rest Leg Pain
- Interventions
- Remodulin® (treprostinil sodium) Injection
- Drug
- Lead sponsor
- United Therapeutics
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2004
- U.S. locations
- 7
- States / cities
- Tampa, Florida • Worcester, Massachusetts • Minneapolis, Minnesota + 4 more
- Conditions
- Critical Limb Ischemia, Critical Lower Limb Ischemia, Peripheral Artery Disease, Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia, Arterial Occlusive Diseases, Arterial Occlusion, Arterial Disease, Peripheral Artery Occlusion, Peripheral Vascular Disease, Peripheral Ischemia, Vascular Diseases
- Interventions
- LimFlow System
- Device
- Lead sponsor
- LimFlow, Inc.
- Industry
- Eligibility
- 18 Years to 95 Years
- Enrollment
- 105 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2025
- U.S. locations
- 20
- States / cities
- San Francisco, California • Torrance, California • New Haven, Connecticut + 15 more
- Conditions
- Critical Limb Ischemia
- Interventions
- Liposuction, Stem Cell Injection
- Procedure · Other
- Lead sponsor
- Ageless Regenerative Institute
- Industry
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2017
- U.S. locations
- 1
- States / cities
- Miami, Florida
- Conditions
- Critical Limb Ischemia
- Interventions
- BMAC injection, Placebo injection
- Device
- Lead sponsor
- Harvest Technologies
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 97 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2015
- U.S. locations
- 34
- States / cities
- Birmingham, Alabama • El Dorado, Arkansas • Los Angeles, California + 30 more
- Conditions
- Critical Limb Ischemia, Peripheral Arterial Disease, Peripheral Vascular Disease
- Interventions
- Bone marrow concentration device, Placebo procedure (sham)
- Device · Procedure
- Lead sponsor
- Zimmer Biomet
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 153 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2020
- U.S. locations
- 25
- States / cities
- Little Rock, Arkansas • Sacramento, California • Miami, Florida + 20 more
- Conditions
- Critical Limb Ischemia
- Interventions
- Oxygenesys(TM) Dissolved Oxygen Dressing
- Device
- Lead sponsor
- Halyard Health
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 1
- States / cities
- New Haven, Connecticut
- Conditions
- Peripheral Arterial Disease, Critical Limb Ischemia, Critical Lower Limb Ischemia
- Interventions
- FLIR One Pro LT
- Device
- Lead sponsor
- University Hospitals Cleveland Medical Center
- Other
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 3
- States / cities
- Beachwood, Ohio • Cleveland, Ohio • Parma, Ohio
- Conditions
- Critical Limb Ischemia, Severe Leg Ischemia, Peripheral Artery Disease, Peripheral Vascular Disease
- Interventions
- MESENDO, Placebo
- Biological
- Lead sponsor
- TCA Cellular Therapy
- Industry
- Eligibility
- 19 Years and older
- Enrollment
- 35 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 1
- States / cities
- Covington, Louisiana
- Conditions
- Peripheral Vascular Diseases
- Interventions
- NightHawk
- Device
- Lead sponsor
- FoxHollow Technologies
- Industry
- Eligibility
- Not listed
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007
- U.S. locations
- 1
- States / cities
- Austin, Texas
- Conditions
- Critical Limb Ischemia, Peripheral Arterial Disease, Peripheral Vascular Disease
- Interventions
- ALDH-br bone marrow cells vs. mononuclear bone marrow cells
- Procedure
- Lead sponsor
- Aldagen
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 5
- States / cities
- Birmingham, Alabama • Atlanta, Georgia • Indianapolis, Indiana + 2 more
- Conditions
- Peripheral Vascular Disease
- Interventions
- Ecraprost in lipid emulsion
- Drug
- Lead sponsor
- Tanabe Pharma Corporation
- Industry
- Eligibility
- 40 Years and older
- Enrollment
- 560 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2001 – 2004
- U.S. locations
- 20
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Glendale, California + 17 more
- Conditions
- Critical Limb Ischemia
- Interventions
- Open surgical revascularization, Endovascular revascularization
- Procedure · Device
- Lead sponsor
- Carelon Research
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 1,843 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2022
- U.S. locations
- 144
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 102 more
- Conditions
- Chronic Total Occlusion of Artery of the Extremities
- Interventions
- FastWire System - Peripheral
- Device
- Lead sponsor
- Versono Medical Ltd
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 65 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 6
- States / cities
- Wilmington, Delaware • Cocoa, Florida • Davenport, Iowa + 3 more
- Conditions
- Peripheral Vascular Diseases
- Interventions
- Bypass, Silverhawk Plaque Excision
- Procedure
- Lead sponsor
- FoxHollow Technologies
- Industry
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2006
- U.S. locations
- 31
- States / cities
- Birmingham, Alabama • Los Angeles, California • Sacramento, California + 26 more
- Conditions
- Ischemia
- Interventions
- Angiogram, Medtronic DCB (paclitaxel)/stent, Angiogram, Bard DCB (paclitaxel)/stent
- Device
- Lead sponsor
- Rabih A. Chaer
- Other
- Eligibility
- 40 Years to 95 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2022
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania